Masitinib
Masitinib (pronunciation: ma-si-ti-nib) is a tyrosine kinase inhibitor that is primarily used in the treatment of certain types of cancer and inflammatory diseases. It is a selective inhibitor of the c-Kit, PDGFR and Lyn kinases, which are involved in various cellular processes such as cell growth, differentiation, and survival.
Etymology
The name "Masitinib" is derived from the chemical name "N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-methylpiperazin-1-yl)piperidine-1-carboxamide". The term "Masitinib" is a nonproprietary name used to identify this specific chemical compound.
Usage
Masitinib is used in the treatment of mastocytosis, a rare disease characterized by an excessive accumulation of mast cells in the body. It is also used in the treatment of certain types of gastrointestinal stromal tumors (GISTs), which are a type of cancer that originates in the digestive tract. In addition, Masitinib is being investigated for its potential use in treating Alzheimer's disease, multiple sclerosis, and asthma.
Related Terms
- Tyrosine kinase inhibitor
- Cancer
- Inflammatory diseases
- Mastocytosis
- Gastrointestinal stromal tumors
- Alzheimer's disease
- Multiple sclerosis
- Asthma
See Also
External links
- Medical encyclopedia article on Masitinib
- Wikipedia's article - Masitinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski